These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

703 related items for PubMed ID: 20812848

  • 21. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V, Popova D, Kicheva M, Todorova Y, Markova R, Martinova F, Elenkov I, Yankova M.
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [Abstract] [Full Text] [Related]

  • 22. Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients.
    Keh CE, Shen JM, Hahn B, Hallahan CW, Rehm CA, Thaker V, Wynne SM, Davey RT, Lane HC, Sereti I.
    AIDS; 2006 Feb 14; 20(3):361-9. PubMed ID: 16439869
    [Abstract] [Full Text] [Related]

  • 23. Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients.
    Bastard JP, Soulié C, Fellahi S, Haïm-Boukobza S, Simon A, Katlama C, Calvez V, Marcelin AG, Capeau J.
    Antivir Ther; 2012 Feb 14; 17(5):915-9. PubMed ID: 22436412
    [Abstract] [Full Text] [Related]

  • 24. Reduced CD127 expression on peripheral CD4+ T cells impairs immunological recovery in course of suppressive highly active antiretroviral therapy.
    Bai F, Bellistrì GM, Tincati C, Savoldi A, Pandolfo A, Bini T, Carpani G, Sinigaglia E, Marchetti G, d'Arminio Monforte A.
    AIDS; 2010 Oct 23; 24(16):2590-3. PubMed ID: 20935556
    [Abstract] [Full Text] [Related]

  • 25. Interleukin-7 (IL-7): immune function, involvement in the pathogenesis of HIV infection and therapeutic potential.
    Beq S, Delfraissy JF, Theze J.
    Eur Cytokine Netw; 2004 Oct 23; 15(4):279-89. PubMed ID: 15627636
    [Abstract] [Full Text] [Related]

  • 26. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.
    Liu ZY, Guo FP, Han Y, Qiu ZF, Zuo LY, Li YL, Li TS.
    Chin Med J (Engl); 2009 Oct 20; 122(20):2497-502. PubMed ID: 20079166
    [Abstract] [Full Text] [Related]

  • 27. Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system.
    Nemes E, Lugli E, Nasi M, Ferraresi R, Pinti M, Bugarini R, Borghi V, Prati F, Esposito R, Cossarizza A, Mussini C.
    AIDS; 2006 Oct 24; 20(16):2021-32. PubMed ID: 17053348
    [Abstract] [Full Text] [Related]

  • 28. Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment.
    Marchetti G, Meroni L, Varchetta S, Terzieva V, Bandera A, Manganaro D, Molteni C, Trabattoni D, Fossati S, Clerici M, Galli M, Moroni M, Franzetti F, Gori A.
    J Infect Dis; 2002 Sep 01; 186(5):606-16. PubMed ID: 12195347
    [Abstract] [Full Text] [Related]

  • 29. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
    Keane NM, Price P, Lee S, Almeida CA, Stone SF, James I, French MA.
    HIV Med; 2004 Nov 01; 5(6):407-14. PubMed ID: 15544692
    [Abstract] [Full Text] [Related]

  • 30. Increased plasma interleukin-7 level correlates with decreased CD127 and Increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection.
    Sasson SC, Zaunders JJ, Zanetti G, King EM, Merlin KM, Smith DE, Stanley KK, Cooper DA, Kelleher AD.
    J Infect Dis; 2006 Feb 15; 193(4):505-14. PubMed ID: 16425129
    [Abstract] [Full Text] [Related]

  • 31. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S, Gona P, Dankner W, Weinberg A, Yogev R, Gershon A, Rathore M, Read JS, Huang S, Elgie C, Hudgens K, Hughes W.
    Pediatrics; 2005 Apr 15; 115(4):e488-94. PubMed ID: 15772172
    [Abstract] [Full Text] [Related]

  • 32. Polymorphism in interleukin-7 receptor α gene is associated with faster CD4⁺ T-cell recovery after initiation of combination antiretroviral therapy.
    Hartling HJ, Thørner LW, Erikstrup C, Harritshøj LH, Kronborg G, Pedersen C, Larsen CS, Helleberg M, Gerstoft J, Obel N, Ullum H, Nielsen SD.
    AIDS; 2014 Jul 31; 28(12):1739-48. PubMed ID: 24911352
    [Abstract] [Full Text] [Related]

  • 33. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomão R, Kallás EG, de Moraes-Pinto MI.
    Cytometry B Clin Cytom; 2007 Jan 15; 72(1):14-21. PubMed ID: 17041945
    [Abstract] [Full Text] [Related]

  • 34. Interleukin-7 signalling defects in naive CD4+ T cells of HIV patients with CD4+ T-cell deficiency on antiretroviral therapy are associated with T-cell activation and senescence.
    Tanaskovic S, Fernandez S, Price P, French MA.
    AIDS; 2014 Mar 27; 28(6):821-30. PubMed ID: 24499954
    [Abstract] [Full Text] [Related]

  • 35. CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy.
    Steel A, John L, Shamji MH, Henderson DC, Gotch FM, Gazzard BG, Kelleher P.
    HIV Med; 2008 Feb 27; 9(2):118-25. PubMed ID: 18257774
    [Abstract] [Full Text] [Related]

  • 36. Reduced mortality and CD4 cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults.
    Erikstrup C, Kallestrup P, Zinyama-Gutsire RB, Gomo E, Butterworth AE, Pedersen BK, Ostrowski SR, Gerstoft J, Ullum H.
    AIDS; 2007 Nov 12; 21(17):2283-91. PubMed ID: 18090276
    [Abstract] [Full Text] [Related]

  • 37. Distinct mechanisms of T cell reconstitution can be identified by estimating thymic volume in adult HIV-1 disease.
    Kalayjian RC, Spritzler J, Pu M, Landay A, Pollard RB, Stocker V, Harthi LA, Gross BH, Francis IR, Fiscus SA, Tebas P, Bosch RJ, Valcour V, Lederman MM, Adult AIDS Clinical Trials Group 5015 and 5113 Study Teams.
    J Infect Dis; 2005 Nov 01; 192(9):1577-87. PubMed ID: 16206072
    [Abstract] [Full Text] [Related]

  • 38. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ, Su Z, Havlir DV, Robertson KR, Coombs RW, Cain P, Peterson T, Krambrink A, Jahed N, McMahon D, Margolis DM, AIDS Clinical Trials Group 5170 Study Team.
    J Infect Dis; 2007 May 15; 195(10):1426-36. PubMed ID: 17436222
    [Abstract] [Full Text] [Related]

  • 39. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M, Keane N, McKinnon E, Phung S, Price P.
    HIV Med; 2007 Apr 15; 8(3):148-55. PubMed ID: 17461858
    [Abstract] [Full Text] [Related]

  • 40. Differential alterations of the CD4 and CD8 T cell subsets in HIV-infected patients on highly active antiretroviral therapy with low CD4 T cell restoration.
    Méndez-Lagares G, García-Pergañeda A, del Mar del Pozo-Balado M, Genebat M, Ruiz-Mateos E, García García M, Muñoz-Fernández MÁ, Pacheco YM, Leal M.
    J Antimicrob Chemother; 2012 May 15; 67(5):1228-37. PubMed ID: 22287235
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.